Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Addex Therapeutics (ADXN) Assets Average: 2022-2025

Historic Assets Average for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $10.4 million.

  • Addex Therapeutics' Assets Average rose 9.78% to $10.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.4 million, marking a year-over-year increase of 9.78%. This contributed to the annual value of $8.7 million for FY2024, which is 24.95% up from last year.
  • As of Q2 2025, Addex Therapeutics' Assets Average stood at $10.4 million, which was down 8.42% from $11.4 million recorded in Q1 2025.
  • Addex Therapeutics' Assets Average's 5-year high stood at $15.5 million during Q2 2022, with a 5-year trough of $4.5 million in Q1 2024.
  • For the 3-year period, Addex Therapeutics' Assets Average averaged around $9.5 million, with its median value being $9.2 million (2023).
  • In the last 5 years, Addex Therapeutics' Assets Average tumbled by 45.07% in 2024 and then spiked by 151.11% in 2025.
  • Over the past 4 years, Addex Therapeutics' Assets Average (Quarterly) stood at $10.6 million in 2022, then plummeted by 42.73% to $6.1 million in 2023, then skyrocketed by 115.35% to $13.1 million in 2024, then rose by 9.78% to $10.4 million in 2025.
  • Its Assets Average was $10.4 million in Q2 2025, compared to $11.4 million in Q1 2025 and $13.1 million in Q4 2024.